@stayinformedwithsanil

Should you apply for the SBI Funds Management IPO? In this detailed Wiremesh analysis, we review the company's business model, valuation, P/E comparison with listed peers, current Grey Market Premium (GMP), key risks, and our Wiremesh Investment Score. Discover whether this IPO is suitable for long-term investors, listing gain seekers, or both before making your investment decision

Nifty Outlook: Is This a Relief Rally or a Trap? Nifty Outlook: A Strong Bounce — But What’s Really Driving It? The current Nifty outlook presents a setup that feels encouraging on the surface, but deserves a closer look. After slipping to 22,995, the market has rebounded sharply to 23,581 in just two sessions. Moves like this tend to trigger a familiar feeling — the sense that one might be getting left behind. But what stands out this time is not just the bounce — it’s what’

ndian IT stocks have fallen sharply. AI is rewriting the rules of software. And suddenly, a sector that once felt predictable feels anything but. Some believe this is the beginning of the end. Others argue it’s the start of something bigger. Both sides sound convincing — which is exactly what makes this moment uncomfortable. The real question isn’t whether Indian IT will survive. It’s whether investors are prepared for what it’s becoming.

Markets are entering 2026 with strong narratives and even stronger prices. When almost everything looks “right,” the real risk often hides in what’s already priced in.

The Indian stock market outlook is being reshaped by GST cuts, expected RBI rate reductions and the high-potential US–India trade deal — but global risks like Japan’s bond shock and the US tech bubble mean investors need smart strategies, not blind optimism. This article breaks down what to expect over the next 6 months, 1 year and 3 years, and how portfolios can navigate volatility with equities, gold and silver ETFs.

The Indian IPO market is buzzing this November 2025 with high-profile issues like Lenskart, Orkla India, and Studds Accessories. Check out the Best IPO and GMP analysis to see which offers are truly worth your bid — from short-term listing gains to long-term compounding potential.